爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

merck serono limited - somatropin - solution for injection - 5.83 mg/ml - somatropin and somatropin agonists

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

merck serono limited - somatropin, recombinant human growth hormone - pdr+solv for soln for inj - 8 milligram - somatropin and somatropin agonists

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

merck serono limited - somatropin - solution for injection - 8 mg/ml - somatropin and somatropin agonists

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

merck serono limited - metformin hydrochloride - film coated tablet - 850 milligram - biguanides

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

merck serono limited - metformin hydrochloride - film coated tablet - 500 milligram - biguanides

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

merck serono limited - metformin hydrochloride - film coated tablet - 1000 milligram - biguanides

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

merck serono limited - progesterone - vaginal gel - 8 %w/w - progestogens

以色列 - 英文 - Ministry of Health

merck serono ltd - avelumab - concentrate for solution for infusion - avelumab 20 mg / 1 ml - metastatic merkel cell carcinomabavencio is indicated for the treatment of adult patients with metastatic merkel cell carcinoma (mcc).locally advanced or metastatic urothelial carcinomafirst-line maintenance treatment of urothelial carcinomabavencio is indicated for the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma (uc) that has not progressed with first-line platinum-containing chemotherapy.previously-treated urothelial carcinomabavencio is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma (uc) who:• have disease progression during or following platinum-containing chemotherapy• have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy advanced renal cell carcinomabavencio in combination with axitinib is indicated for the first-line treatment of patients with advanced renal cell carcinoma (rcc).

以色列 - 英文 - Ministry of Health

merck serono ltd - tepotinib as hydrochloride hydrate - film coated tablets - tepotinib as hydrochloride hydrate 225 mg - tepotinib - tepmetko is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (nsclc) harbouring a met tyrosine kinase receptor exon 14 (metex14) skipping mutation.

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

merck serono limited - bisoprolol hemifumarate - film coated tablet - 1.25 milligram - beta blocking agents, selective